Home Suzanne Lepage

A recent survey by Innovative Medicines Canada found there are growing listing delays among Canada’s private drug plans, said Joe Farago, the organization’s executive director of private payers and investment, during a session at Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in December. The survey noted private payer review times can take […]

  • January 22, 2024 January 18, 2024
  • 08:00

Third-party administrators are key health benefits industry players that have grown in size and influence but are relatively unknown and sometimes misunderstood. The Third-Party Administrators’ Association of Canada represents the majority of TPAs in Canada, which together manage benefits plans for more than 5.3 million Canadians through 70,000 employers, says Mike McClenahan, the TPAAC’s president […]

  • December 16, 2022 December 15, 2022
  • 08:52

Migraine affects 12 to 15 per cent of Canadians, said Dr. Elizabeth Leroux, a Montreal-based neurologist, president of the Canadian Headache Society and chair of Migraine Canada, during a webinar hosted by Benefits Canada and sponsored by Lundbeck Canada Inc. in October. According to the World Health Organization, a severe migraine attack is as disabling […]

  • November 16, 2021 November 16, 2021
  • 09:00

Plan sponsors with growing concerns about benefits plan sustainability should focus on a few strategic pharmacy benefits plan issues, said Mark Rolnick, executive vice-president of pharmacy innovation and patient experience at Green Shield Canada, during a session at Benefits Canada’s Face to Face Drug Plan Management Forum on Dec. 9, 2020. He recommended that plans […]

  • January 15, 2021 April 23, 2021
  • 09:00